Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Loss of Tumor Suppressor Gene Promotes Breast Cancer Metastasis into the Lungs

By BiotechDaily International staff writers
Posted on 08 Jun 2014
Image: Graphic explaining the consequences of the loss of function of RARRES3 for breast cancer lung metastasis (Photo courtesy of the Institute for Research in Biomedicine).
Image: Graphic explaining the consequences of the loss of function of RARRES3 for breast cancer lung metastasis (Photo courtesy of the Institute for Research in Biomedicine).
Cancer researchers have found that loss of a specific tumor suppressor gene promotes the metastasis of breast cancer cells into the lungs.

Investigators at the Institute for Research in Biomedicine (Barcelona, Spain) characterized the biological activity of RARRES3 (retinoic acid receptor responder protein 3), a recently identified metastasis suppressor gene whose reduced expression in primary breast tumors identifies a subgroup of patients more likely to develop lung metastasis. This work was carried out on samples from mice and in cell lines, and then was validated in 580 samples from human primary breast cancer tumors.

Results published in the May 27, 2014, online edition of the journal EMBO Molecular Medicine revealed that the loss of function of the RARRES3 gene in primary breast tumor cells promoted metastasis to the lung. RARRES3 downregulation engaged metastasis-initiating capabilities by facilitating adhesion of the tumor cells to the lung parenchyma. In addition, impaired tumor cell differentiation due to the loss of RARRES3 phospholipase A1/A2 activity also contributed to lung metastasis.

Looking at the results from the other direction, it was clear that the investigators had shown that RARRES3 blocked adhesion to the lung parenchyma and, second, the phospholipase activity of RARRES3 stimulated differentiation attributes, thus blunting metastasis-initiating functions at the lung required for the breast cancer cells to establish a lesion.

"RARRES3 is suppressed in estrogen receptor-negative (ER-) breast cancer tumors, thus stimulating the later invasion of the cancer cells and conferring them a greater malignant capacity," said senior author Dr. Roger Gomis, head of the growth control and cancer metastasis laboratory at the Institute for Research in Biomedicine. "The transformation of a normal cell into an invasive tumor cell is not just about acquiring capacities but equally important is the loss of certain genes, such as RARRES3."

Related Links:

Institute for Research in Biomedicine



Channels

Drug Discovery

view channel

Curcumin Used to Treat Alzheimer’s Disease

Curcumin, a natural substance found in the spice turmeric, has been used by many Asian cultures for centuries. Now, new research suggests that a close chemical analog of curcumin has properties that may make it useful as a treatment for Alzheimer’s disease. “Curcumin has demonstrated ability to enter the brain, bind... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Lab Technologies

view channel
Image: MIT researchers have designed a microfluidic device that allows them to precisely trap pairs of cells (one red, one green) and observe how they interact over time (Photo courtesy of Burak Dura, MIT).

New Device Designed to See Communication between Immune Cells

The immune system is a complicated network of many different cells working together to defend against invaders. Effectively combating an infection depends on the interactions between these cells.... Read more

Business

view channel

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market. Powered by Intel Xeon processors, Dedicated Computing is providing a range of... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.